Penumbra Inc (PEN)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $12.65B
Last updated: Nov 17, 2026 at 11:05 AM ET
Penumbra Inc (PEN) Stock Forecast
Analysts expect Penumbra (PEN) to earn $4.91 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.61B. Of 17 analysts, 3 rate the stock Buy or Strong Buy, 14 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.76, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 18% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 5.9% |
| Buy | 2 | 11.8% |
| Hold | 14 | 82.4% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 17
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 25.7% and revenue estimates rise 12.4%.
- Fiscal year ending Dec 31, 2026
- $4.91
- EPS consensus, revenue $1.61B
- Fiscal year ending Dec 31, 2027
- $6.17
- EPS consensus, revenue $1.81B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.91 | $4.32 to $5.43 | 11 | $1.61B | $1.59B to $1.62B | 9 |
| Dec 31, 2027 | $6.17 | $5.45 to $7.06 | 11 | $1.81B | $1.77B to $1.84B | 13 |
Quarterly Estimates
The EPS consensus falls from $1.44 for the quarter ending Dec 31, 2026 to $1.40 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.44 | $1.10 to $1.69 | 11 | $434.51M | $406.70M to $465.22M | 12 |
| Mar 31, 2027 | $1.40 | $1.33 to $1.49 | 4 | $424.57M | $422.52M to $425.80M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 6 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 3 |
| Fiscal year ending Dec 31, 2027 | 1 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.7% from $4.60.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.91 | $4.90 | $4.81 | $4.79 | $4.60 | +6.7% |
| Fiscal year ending Dec 31, 2027 | $6.17 | $6.16 | $6.13 | $6.13 | $6.13 | +0.6% |
| Quarter ending Mar 31, 2027 | $1.40 | $1.40 | $1.39 | $1.39 | $1.39 | +0.6% |
Frequently Asked Questions About PEN
What is the PEN stock forecast?
Consensus analyst estimates put Penumbra's EPS at $4.91 for the fiscal year ending Dec 31, 2026, on revenue of $1.61B. The consensus rating from 17 analysts is Hold.
How do analysts rate PEN stock?
Of 17 analysts covering Penumbra, 1 rates it Strong Buy, 2 Buy, 14 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from PEN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.91, with estimates from $4.32 to $5.43 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.17, with estimates from $5.45 to $7.06 from 11 analysts.
What revenue do analysts expect from Penumbra next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.61B, with estimates from $1.59B to $1.62B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.81B, with estimates from $1.77B to $1.84B.
How many analysts cover PEN?
17 analysts rate Penumbra stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PEN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts